Background. Recent evidence suggests that dopamine (DA) agonist-induced disruption of prepulse inhibition (PPI) depends on basal PPI values, in a manner that suggests an inverted U-shaped relationship between PPI and prefrontal DA levels. This is the first study to examine possible genetic determinants of PPI and the catechol O-methyltransferase (COMT) Val158Met polymorphism, the main catabolic pathway of released DA in the prefrontal cortex (PFC).
Introduction
Prepulse inhibition (PPI) is a measure of inhibitory control of information processing in which a weak sensory stimulus (the prepulse) inhibits the startle response to a subsequent sudden intense stimulus (pulse). PPI is thought to reflect 'sensorimotor gating ', a form of central nervous system inhibition wherein distracting sensory information is filtered out during the early stages of processing so that attention can be focused on more salient features of the environment (Braff et al. 1978 ; .
PPI is a widely used surrogate measure of psychosis in animal models. It is also considered a candidate endophenotype for schizophrenia (Braff & Light, 2005 ; Calkins et al. 2007 ) because of its high heritability (Anokhin et al. 2003) and the presence of PPI deficits in the unaffected first-degree relatives of probands (Cadenhead et al. 2000 ; Kumari et al. 2005) . However, the genetic architecture of the PPI endophenotype is in its infancy. To date, only one study has reported PPI deficits in both schizophrenia and healthy control populations with a missense mutation on rs3924999 of the neuregulin 1 gene, one of the leading candidate genes in schizophrenia (Hong et al. 2007) .
Animal studies show that PPI involves a widely distributed cortico-striato-pallido-pontine network (Swerdlow et al. 1991 (Swerdlow et al. , 2001a potently regulated by dopaminergic neurotransmission (Swerdlow et al. 1992 ; Koch & Schnitzler, 1997 ; Geyer et al. 2001) . Dopamine (DA) agonists disrupt PPI in rats (Mansbach et al. 1988 ; Swerdlow et al. 1998 Swerdlow et al. , 2001b Swerdlow et al. , 2002 Swerdlow et al. , 2003 and this DA-stimulated loss of PPI has been proposed as an animal model with face, predictive and construct validity for the loss of sensorimotor gating in schizophrenia (Swerdlow et al. 1994) . There is now abundant evidence (for reviews, see Harrison & Weinberger, 2005 ; Tunbridge et al. 2006 ) that COMT impacts critically on dopaminergic transmission. A polymorphism in the COMT gene, leading to an amino acid substitution [valine (Val) to methionine (Met)], results in the Met/Met variant showing 40 % less enzymatic activity than the Val/Val (Chen et al. 2004 ). This COMT polymorphism determines basal cortical DA neurotransmission levels that, in turn, regulate striatal DA activity. Indeed, higher COMT activity, as conferred by the Val158 allele, is associated with elevated midbrain DA synthesis (Meyer-Lindenberg et al. 2005) . This suggests that the Val158 allele may indirectly increase striatal dopaminergic function, thus reducing PPI. The COMT Val158Met polymorphism has been associated with auditory information gating deficits (Lu et al. 2007) , and this is the first study to test the effects of this polymorphism on PPI in healthy male subjects.
Method

Subjects
One hundred and fifteen subjects were recruited from a pooled volunteer list of university students. We restricted the sample to men to avoid PPI variability related to gender (Swerdlow et al. 1993 ; Aasen et al. 2005) and menstrual cycle (Swerdlow et al. 1997) and to avoid the regulatory effect on the expressed activity of the COMT enzyme by the circulatory oestrogens in women (Salama et al. 2006) . Inclusion criteria included right-handedness, absence of personal history of head trauma, medical and neurological conditions, or use of prescribed and recreational drugs ; absence of personal or family (up to second-degree relatives) history of DSM-IV Axis I disorders and hearing threshold greater than 40 dB at 1 kHz. All subjects underwent psychiatric assessment using the Mini-International Neuropsychiatric Interview (Sheehan et al. 1998) and physical assessment including a urine toxicology screening and audiometry using a Kamplex AC30 Clinical Audiometer (PC Werth Ltd, London, UK). Eight subjects were excluded because of a family history of psychiatric illness, 10 subjects were startle nonresponders (mean startle amplitude <10 mV) and four had a positive drug screen. Ninety-three Greek/ Caucasian healthy males aged 18-35 years (mean¡ S.D., 26.2¡4.0) entered and completed the study. The study was approved by the Ethics Committee of the University of Crete. All participants gave written informed consent before screening. Participants were seen and assessed on a single occasion.
Genotyping
Genomic DNA was extracted from venous blood samples. The COMT Val158Met genotype was determined by restriction fragment length polymorphism (RFLP) after polymerase chain reaction (PCR) amplification and digestion with NlaIII, similarly to a previously described methodology (Lachman et al. 1996) .
Measurement of the startle response
A commercially available electromyographic (EMG) startle system (EMG SR-LAB, San Diego Instruments, San Diego, CA, USA) was used to examine the eyeblink component of the acoustic startle response from the right orbicularis oculi muscle. Equipment descriptions and set-up have been described previously in detail (Bitsios et al. 2005) . Pulses consisted of 40-ms, 115-dB white noise bursts, and prepulses consisted of 20-ms, 75-dB and 85-dB white noise bursts over 70-dB background noise. Recording began with 3 min of acclimation when only background noise was present. The recording period comprised 12 pulse-alone trials and 24 prepulse-pulse trials. Two lead intervals (onset to onset) were used (60 ms, 120 ms). For each interval, there were six trials with the 75-dB prepulse and six with the 85-dB prepulse. All trials were presented in pseudo-random order with the constraint that no two identical trials occurred in succession. The intertrial interval varied between 9 s and 23 s (average 15 s). The entire test session lasted approximately 15 min. No specific instructions were given to the subjects with regards to the prepulses (passive PPI paradigm).
The EMG data were at first inspected on a trial-totrial basis (to exclude erroneous trials for a particular subject) and then scored by the system's analytic programme for response amplitude and latencies. Trials were rejected (<5 %) if excessive EMG activity (>20 digital units) was observed during the first 20 ms of recording or when onset latencies (defined by a shift of 20 digital units from the baseline value, occurring within 20-85 ms after the onset of the pulse stimulus) and peak latencies differed by more than 95 ms (Braff et al. , 1999 . The maximum absolute amplitude of the raw EMG data occurring in the 20-150-ms time window of the non-rejected trials was scored offline and stored for averaging and data analysis. 
Statistical analysis
Results
Thirty subjects were homozygous for Val/Val, 48 were heterozygous for Val/Met, and 15 were homozygous for Met/Met, a distribution consistent with HardyWeinberg expectations (x 2 =0.33, df=2, p=0.85). There were no differences in demographic and startle variables between the three genotype groups (Table 1) and polynomial contrasts failed to show a significant linear trend in baseline startle amplitude from the Val/Val to the Met/Met group. As an additional control to rule out gross stratification effects, genotyping was also performed for five unrelated gene polymorphisms. A contingency table approach (Raymond & Rousset, 1995 ; Roussos et al. in press) was used to test for differences in the allelic distributions of these additional markers for COMT Val/Val and Met/Met subjects. This analysis revealed no significant differences at p<0.05 in allele frequencies for each locus (Table 2 ). This finding makes genetic inhomogeneity of the tested population unlikely. Figure 1 shows the (F values <2.8, p>0.08) . ANOVAs with identical factorial design showed that none of the polymorphisms shown in Table 2 had a significant effect on PPI in our sample, as evidenced by lack of significant genotype main effects or interactions involving genotype (all F values <1). Table 4 shows the %PPI in each genotype group for these polymorphisms and their distribution in our sample.
Discussion
We found that in healthy males COMT polymorphism is associated with PPI levels. Specifically, we observed a linear relationship between PPI levels and Val allele load ; Val homozygotes had the lowest PPI, Met homozygotes the highest, and heterozygotes were intermediate for both prepulse intensities and both lead interval conditions. Importantly, our findings were obtained from a homogeneous cohort of healthy male subjects and cannot be attributed to differences in demographic characteristics or genetic inhomogeneity because the genotype groups did not differ in that respect (Tables 1 and 2 ). Our observations resonate closely with results from recent functional magnetic resonance imaging (fMRI) literature showing that, relative to Met-loading subjects, Val homozygotes underperform in prefrontal cortex (PFC)-related tasks and/or have prefrontal hyperactivation (Egan et al. 2001 ; Bilder et al. 2002 ; Malhotra et al. 2002 ; Mattay et al. 2003 ; Bertolino et al. 2004 ; Winterer et al. 2006) . The lower PPI levels in our Val loading subjects are also suggestive of less efficient information processing and increased prefrontal neuronal ' noise ' in individuals with the COMT Val allele (Egan et al. 2001 ; Winterer & Goldman, 2003 ; Winterer et al. 2006) . PPI in rodents is modulated by activity in corticostriato-pallido-pontine circuitry (Swerdlow et al. 1991 (Swerdlow et al. , 2001a of which the PFC is a crucial node Swerdlow et al. 1995 ; Ellenbroek et al. 1996 ; Broersen et al. 1999 ; Japha & Koch, 1999 ; Zavitsanou et al. 1999 ; Lacroix et al. 2000 ; Yee, 2000) . Our observations suggest that PFC DA transmission may be an important neural mechanism that modulates PPI in humans. The findings of the present study extend recent reports from our laboratory Giakoumaki et al. 2006 ) and others (Csomor et al. 2008) showing (a) an association between PPI levels and performance on PFC-related tasks of working memory and planning, and (b) changes in PPI levels following administration of DA agonists or antagonists depending on basal PPI (Swerdlow et al. 2003 ; Bitsios et al. 2005 ; Csomor et al. 2008) . Graham (1975) proposed that PPI reflects Table 4 . %PPI (mean¡S.D.) at all trial types, when the sample was regrouped for BDNF (M/M n=2, V/M n=34, V/V n=57), DRD2A1 (A1/A1 n=3, A1/A2 n=19, A2/A2 n=71), DAT1 (9/9 n=11, 9/10 n=37, 10/10 n=45), DRD1 (A/A n=47, A/G n=41, G/G n=5), and ZDHHC8 (A/A n=6, A/G automatic pre-attentive processes but recent evidence suggests that, even at this early stage of information processing, PPI is associated with cognitive processes controlled in a ' top-down' fashion by the PFC (Hazlett et al. 2001) . This is supported by functional imaging studies in healthy individuals showing increased frontal and parietal cortical activation in attentionally modulated (Hazlett et al. 1998 ) and passive PPI paradigms (Kumari et al. 2003 (Kumari et al. , 2007 Postma et al. 2006 ; Campbell et al. 2007) . Animal studies also support a close link between PPI and PFC DA activity. Reductions in DA activity in the PFC after local injection of selective D2 or D1 antagonists or 6-hydroxydopamine lesions result in significant PPI reduction Ellenbroek et al. 1996 ; Zavitsanou et al. 1999) . Conversely, increased PFC DA activity after local apomorphine infusions also disrupts PPI (Broersen et al. 1999 ; Lacroix et al. 2000) .
Our results also strengthen the model of an interaction between prefrontal DA levels and PPI according to an inverted U-shaped curve (Bitsios et al. 2005) . Our findings support our previous suggestion that the PFC influences PPI levels and, by inference, the early stages of attentional processing Giakoumaki et al. 2006 ). The COMT is also expressed in other brain regions involved in PPI modulation, particularly the hippocampus (Swerdlow et al. 2001a ; Matsumoto et al. 2003) , which may have influenced our results. By extending the influence of the COMT genotype on PPI in healthy subjects, the present study contributes to the understanding of the genetic architecture of the PPI endophenotype.
Gender differences in the effects of COMT polymorphism on human PPI are possible because no effect of COMT polymorphism on PPI was found in a recent study with 96 German females (Montag et al. 2008) . Unfortunately, however, that study is not directly comparable to the present one because of the different stimulus parameters used in startle elicitation. We used standard stimulation with a 40-ms, 115-dB pulse with nearly instantaneous rise time (<1 ms) and two 20-ms prepulses, 5-dB and 15-dB above background, whereas Montag et al. (2008) used a weaker pulse (106-dB, 35-ms, 5-ms rise time) and one prepulse, 19 dB above background. For a given prepulse, PPI increases with weaker pulses (Csomor et al. 2006) , and therefore it is conceivable that small between-group PPI differences may be overriden by a ceiling effect when weak pulses are used. More importantly, prepulses closer to background noise, such as those used in the present study, increase the susceptibility of PPI to modulation by manipulations of dopaminergic transmission, for example PPI disruption by the DA agonist apomorphine (Davis et al. 1990) or attention (Gewirtz & Davis, 1995) .
To our knowledge, this is the first demonstration in humans of a DA gene-specific influence on PPI levels that may explain observed individual differences. Future studies examining the effect of the COMT Val158Met polymorphism on pharmacological manipulations of the PPI following administration of DA agonists or COMT inhibitors, or the effects on PPI of other COMT polymorphisms that convey differences in enzyme activity (Diatchenko et al. 2005 ; Nackley et al. 2006 ; Roussos et al. in press) , could further enhance our understanding of the relationship between COMT, PPI and cognition.
